Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management

Archives of Ophthalmology

Volumn 126, Issue 4, 2008, Pages 493-499

  Jackson, Kevin M ^a   Scott, Karen E ^b   Graff Zivin, Joshua ^a   Bateman, David A ^b   Flynn, John T ^b   Keenan, Jeremy D ^b   Chiang, Michael F ^b  

^a Columbia University ^*  (United States)

^b Box 92 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRTH WEIGHT; CALCULATION; CLINICAL EVALUATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICARE; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; RETROLENTAL FIBROPLASIA; SENSITIVITY AND SPECIFICITY; TELEMEDICINE; VISUAL ACUITY;

COST OF ILLNESS; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; LASER COAGULATION; OPHTHALMOSCOPY; QUALITY-ADJUSTED LIFE YEARS; RETINOPATHY OF PREMATURITY; SENSITIVITY AND SPECIFICITY; TELEMEDICINE; VISUAL ACUITY;

EID: 42249105678     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.4.493     Document Type: Article

References (59)

1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol. 1988;106(4):471-479.
2. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684-1694.
3. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;102(8):1130-1134.
4. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123(7):991-999.
5. American Academy of Pediatrics, Section on Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2001;108(3):809-811.
6. Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity [published correction appears in Pediatrics. 2006;118(3):1324]. Pediatrics. 2006;117(2):572-576.
7. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2005. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/prelimbirths05/ prelimbirths05.htm. Accessed February 7, 2007.
8. Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518-e525.
9. Gilbert C, Rahi J, Eckstein M, et al. Retinopathy of prematurity in middle-income countries. Lancet. 1997;350(9070):12-14.
10. American Academy of Ophthalmology. Ophthalmologists warn of shortage in specialists who treat premature babies with blinding eye condition. http://www.aao.org/newsroom/release/20060713.cfm. Accessed January 5, 2007.
11. Bashshur RL, Reardon TG, Shannon GW. Telemedicine: a new health care delivery system. Annu Rev Public Health. 2000;21:613-637.
12. Chiang MF, Keenan JD, Starren JB, et al. Accuracy and reliability of remote retinopathy of prematurity diagnosis. Arch Ophthalmol. 2006;124(3):322-327.
13. Chiang MF, Starren JB, Du YE, et al. Remote image based retinopathy of prematurity diagnosis: a receiver operating characteristic analysis of accuracy. Br J Ophthalmol. 2006;90(10):1292-1296.
14. Chiang MF, Keenan JD, Du YE, et al. Assessment of image-based technology: impact of referral cutoff on accuracy and reliability of remote retinopathy of prematurity diagnosis. AMIA Annu Symp Proc. 2005:126-130.
15. Ells AL, Holmes JM, Astle WF, et al. Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study. Ophthalmology. 2003;110(11):2113-2117.
16. Wu C, Petersen RA, Vanderveen DK. Retcam imaging for retinopathy of prematurity screening. J AAPOS. 2006;10(2):107-111.
17. Yen KG, Hess D, Burke B, et al. Telephotoscreening to detect retinopathy of prematurity: preliminary study of the optimum time to employ digital fundus camera imaging to detect ROP. J AAPOS. 2002;6(2):64-70.
18. Lorenz B, Bock M, Muller HM, Massie NA. Telemedicine based screening of infants at risk for retinopathy of prematurity. Stud Health Technol Inform. 1999;64:155-163.
19. Schwartz SD, Harrison SA, Ferrone PJ, Trese MT. Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology. 2000;107(1):25-28.
20. Chiang MF, Wang L, Busuioc M, et al. Telemedical retinopathy of prematurity diagnosis: accuracy, reliability, and image quality. Arch Ophthalmol. 2007;125(11):1531-1538.
21. Scott KE, Kim D, Wang L, et al. Telemedical retinopathy of prematurity diagnosis: agreement between ophthalmoscopic and image-based examinations. Ophthalmology. In press.
22. Grigsby J, Sanders JH. Telemedicine: where it is and where it's going. Ann Intern Med. 1998;129(2):123-127.
23. Perednia DA, Allen A. Telemedicine technology and clinical applications. JAMA. 1995;273(6):483-488.
24. Castillo-Riquelme MC, Lord J, Moseley MJ, et al. Cost-effectiveness of digital photographic screening for retinopathy of prematurity in the United Kingdom. Int J Technol Assess Health Care. 2004;20(2):201-213.
25. Whited JD, Datta SK, Aiello LM, et al. A modeled economic analysis of a digital teleophthalmology system as used by three federal healthcare agencies for detecting proliferative diabetic retinopathy. Telemed J E Health. 2005;11(6):641-651.
26. Whitten PS, Mair FS, Haycox A, et al. Systematic review of cost effectiveness studies of telemedicine interventions. BMJ. 2002;324(7351):1434-1437.
27. Brown MM, Brown GC, Sharma S, et al. Health care economic analyses and value-based medicine. Surv Ophthalmol. 2003;48(2):204-223.
28. Brown GC, Brown MM, Sharma S, et al. Health care economic analyses. Retina. 2004;24(1):139-146.
29. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses: panel on cost-effectiveness in health and medicine. JAMA. 1996;276(16):1339-1341.
30. Palmer EA, Hardy RJ, Dobson V, et al; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol. 2005;123(3):311-318.
31. Palmer EA, Flynn JT, Hardy RJ, et al; Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology. 1991;98(11):1628-1640.
32. Good WV, Hardy RJ, Dobson V, et al; Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics. 2005;116(1):15-23.
33. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical Decision Making. Boston, MA: Butterworth-Heinemann; 1988.
34. Chiang MF, Jiang L, Gelman R, et al. Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol. 2007;125(7):875-880.
35. Gelman R, Jiang L, Du YE, Martinez-Perez ME, Flynn JT, Chiang MF. Plus disease in retinopathy of prematurity: pilot study of computer-based and expert diagnosis. J AAPOS. 2007;11(6):532-540.
36. Ng EYJ, Connolly BP, Mcnamara JA, et al. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years, part 1: visual function and structural outcome. Ophthalmology. 2002;109(5):928-934.
37. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g. Arch Ophthalmol. 2002;120(5):595-599.
38. Brown GC. Vision and quality-of-life. Trans Am Ophthalmol Soc. 1999;97:473-511.
39. Brown GC, Brown MM, Sharma S, et al. Cost-effectiveness of treatment for threshold retinopathy of prematurity. Pediatrics. 1999;104(4):e47.
40. Vermont Oxford Network. Vermont Oxford Network Web page. https://www.vtoxford.org/home.aspx. Accessed October 12, 2006.
41. Horbar J. Vermont Oxford Network Annual VLBW Database Summary, Infants 501 to 1500 Grams Born in 2005. Burlington, VT: Vermont Oxford Network; 2006.
42. Chiang MF, Arons RR, Flynn JT, Starren JB. Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York State patient database. Ophthalmology. 2004;111(7):1317-1325.
43. Yanovitch TL, Siatkowski RM, McCaffree M, Corff KE. Retinopathy of prematurity in infants with birth weight > or = 1250 grams: incidence, severity, and screening guideline cost-analysis. J AAPOS. 2006;10(2):128-134.
44. Centers for Medicare and Medicaid Services. PFS relative value files. http://www.cms.hhs.gov/PhysicianFeeSched/PFSRVF/list.asp. Accessed December 15, 2006.
45. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996:207-363.
46. Brown GC, Brown MM, Sharma S, et al. Value-based medicine and ophthalmology: an appraisal of cost-utility analyses. Trans Am Ophthalmol Soc. 2004;102:177-185.
47. Membreno JH, Brown MM, Brown GC, et al. A cost-utility analysis of therapy for amblyopia. Ophthalmology. 2002;109(12):2265-2271.
48. California Telemedicine and eHealth Center. Telemedicine reimbursement handbook. http://www.cteconline.org. Accessed December 27, 2006.
49. Spooner SA, Gotlieb EM; Committee on Clinical Information Technology; Committee on Medical Liability. Telemedicine: pediatric applications. Pediatrics. 2004;113(6):e639-e643.
50. Centers for Medicare and Medicaid Services. Medicare telehealth services. http://www.cms.hhs.gov/Transmittals/Downloads/R1026CP.pdf. Accessed December 27, 2006.
51. Arias E. United States life tables, 2003. Natl Vital Stat Rep. 2006;54(14):1-40. http://www.cdc.gov/nchs/data/nvsr/nvsr54/nvsr54_14.pdf. Accessed December 15, 2006.
52. Javitt J, Cas RD, Chiang Y. Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity. Pediatrics. 1993;91(5):859-866.
53. Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? tentative guidelines for using clinical and economic evaluations. CMAJ. 1992;146(4):473-481.
54. Kallmes DF, Kallmes MH. Cost-effectiveness of angiography performed during surgery for ruptured intracranial aneurysms. AJNR Am J Neuroradiol. 1997;18(8):1453-1462.
55. Smith KJ, Roberts MS. Antiviral therapies for herpes zoster infections: are they economically justifiable? Pharmacoeconomics. 2000;18(2):95-104.
56. Laws DE, Morton C, Weindling M, Clark D. Systemic effects of screening for retinopathy of prematurity. Br J Ophthalmol. 1996;80(5):425-428.
57. Busbee BG, Brown MM, Brown GC, Sharma S. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology. 2003;110(12):2310- 2317.
58. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology. 2001;108(11):2051-2059.
59. Tang RA, Morales M, Ricur G, Schiffman JS. Telemedicine for eye care. J Telemed Telecare. 2005;11(8):391-396.